 CNBC.com | Novartis drug AfinitorR approved by European Commission to treat patients with ... Reuters Basel, July 30, 2012 -The European Commission has approved Afinitor R (everolimus) tablets* for the treatment of hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer (HR+ advanced breast cancer), in combination with ... Novartis drug Afinitor wins EU nod to treat breast cancer Novartis drug AfinitorĀ® approved by European Commission to treat patients with ... European Commission Oks Novartis' Afinitor Tablets For Treatment Of HR+/HER2 |
